What Zyme Communications does

Zyme Communications is a privately held, UK-based specialist public relations and marketing communications agency focused exclusively on the life science sector. Founded in 2010 and headquartered in Cambridge with a second office in Manchester, the firm serves biotechnology, pharmaceutical, diagnostics, medical technology, and life sciences research companies across Europe and the United States, supporting both early-stage ventures and large multinationals. The senior team of approximately 15 specialists — including dedicated science writers and account directors with combined in-house and agency-side experience — positions the firm as a vertically deep alternative to generalist holding-company agencies.

The company offers four integrated service lines: PR & Media (press releases, article placement, media interviews, copywriting, social media management, and media training); Marketing (campaign development, market research, conference and trade show support, advertising, and lead generation); Design & Branding (website development, brand identity, print collateral, presentations, and video production); and Investor Relations (pitch deck creation, business plan development, and investor-targeted communications). Revenue is generated through project-based and retainer engagements typical of professional services agencies, with pricing tailored to client scope and budget and not publicly disclosed. Customer engagements often span multi-year corporate communications programmes, seed-to-Series-C funding announcement cycles, and ongoing brand-building initiatives.

Zyme differentiates itself through exclusive vertical focus on life sciences, an established international network of life science trade media contacts, and demonstrable placement in high-credibility publications including BioCentury, BioWorld, Drug Discovery World, Endpoints, GEN, and Pharmaceutical Technology. The company is independently owned with no parent entity, no disclosed external funding, and no subsidiaries. Recent 2026 industry recognition — including the Sifted UK & Ireland Leaderboard, Fierce Biotech Fierce 15, multiple Cambridge Independent and Business Weekly Awards, and European Mediscience Awards shortlists — indicates rising market visibility relative to peers in the specialist life science communications niche.

Name

Zyme Communications

Legal name

Zyme Communications Limited

Website

https://zymecommunications.com

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

11–50 employees

Short description

Zyme Communications is a UK-based specialist PR and marketing communications agency serving life science companies across Europe and the USA, offering integrated PR, marketing, design, and investor relations services to both startups and multinationals.

Ownership category

akta.pro rank

Product category

Public Relations Services

NAICS

Public Relations Agencies (541820), Advertising Agencies (541810), Advertising, Public Relations, and Related Services (5418)

SIC

Services-Advertising Agencies (7311), Services-Advertising (7310)

akta.pro primary industry

Healthcare & Life Sciences PR (BPAFADAJ)

akta.pro secondary industry

Healthcare & Life Sciences PR (MPAAADAD)

Keywords

• Life science communications
• Public relations services
• Marketing communications
• Investor relations support
• Branding and design

Headquarters

HQ city

Cambridge

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales

Revenue model

1. PR and Marketing Services: Zyme Communications generates revenue by providing professional PR and marketing services to life science companies. Services include PR & Media, Marketing, Design & Branding, and Investor Relations support. Revenue is likely project-based or retainer arrangements typical of professional services agencies.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Zyme Communications provides PR and marketing services for the life science sector. The agency delivers four integrated service lines: PR & Media (press releases, article placement, media interviews, copywriting, social media management, media training), Marketing (campaign development, conference support, market research, lead generation), Design & Branding (website development, print collateral, brand identity, video production), and Investor Relations (pitch deck creation, investor-specific PR targeting life science trade and financial audiences). Services are tailored to biotech, pharma, diagnostics, and medical technology companies seeking to raise profile, build corporate value, and generate interest from commercial leads, investors, and partners.

Product overview

Zyme Communications is a specialist PR and marketing communications agency for the life science sector, providing a unified service offering rather than a software product. The company offers four integrated service lines: PR & Media (strategic communications, press releases, media relations, social media), Marketing (campaign development, lead generation, market research, event support), Design & Branding (website development, visual identity, presentations, video), and Investor Relations (pitch materials, investor-targeted communications). These services work together to help life science companies raise their profile, build corporate value, and generate interest from commercial leads, investors, and partners.

Differentiator

Problem solved

Functional benefit

Products and services

• PR & Media Services Strategic communications support for life science companies, including press releases, article placement in trade publications, media interviews, copywriting, social media management, and media training designed to build visibility and drive coverage.
• Marketing Services Comprehensive marketing services for life science clients, including conference and trade show support, marketing literature, market research, campaign development, advertising, sponsorship identification, and lead generation.
• Design & Branding Services Creative services for life science companies including website design and development, print collateral, brand identity and logo creation, presentation development, and video production.
• Investor Relations Services Communications support for life science investor engagement, including business plan development, pitch deck creation, and targeted PR aimed at life science trade media and financial audiences.

Quantifiable outcome

• Coverage in top target publications including BioCentury, BioWorld, Drug Discovery World, Endpoints, FirstWord Pharma, GEN, The Pharma Letter, MedNous, News Medical, Pharmaceutical Technology
• +2 more outcomes

Named customers12 records

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators2 records

Expansion highlights6 records

Direct peers

• Makovsky: Makovsky is a US-based integrated communications firm with a strong health and life science practice. Comparable in offering PR, media relations, IR support, and brand communications to life science and healthcare clients.
• Canale Communications: Canale Communications is a US-based life science PR and marketing agency focused exclusively on biotech, pharma, and medtech. Direct competitor offering overlapping services (PR, IR, content) to similar startup and enterprise life science clients.
• LifeSci Communications: LifeSci Communications is a specialist healthcare and life sciences PR and communications agency. Directly comparable in vertical focus and service mix (media relations, scientific communications, IR support) for life science clients.
• ICR (Westwicke): ICR is a strategic communications and advisory firm with a dedicated healthcare and life sciences practice. Comparable in serving biotech clients with integrated PR and IR services, particularly around funding events and corporate milestones.
• Health Unlimited: Health Unlimited is a specialist health and life science communications agency within the larger Unlimited Group. Comparable in vertical focus on healthcare/life science PR, brand communications, and patient/stakeholder engagement.
• BioStrata: BioStrata is a UK-based specialist life science marketing and PR agency. It is a direct peer given its highly comparable positioning as a specialist communications firm serving biotech and life science clients from a similar UK footprint.
• Russo Partners: Russo Partners is a life science and healthcare-focused PR agency. Direct peer offering media relations, IR communications, and corporate communications to biotech and medical technology clients, mirroring Zyme's specialist positioning.

Broad incumbents

• Edelman: Edelman is the world's largest PR firm with a dedicated health and life science practice. Broad incumbent offering global scale and integrated communications that competes with specialist life science agencies on enterprise accounts.
• Fishawack Health: Fishawack Health is a global healthcare communications group offering medical communications, PR, and consulting to pharma and biotech. Broader incumbent operating at significantly larger scale across multiple life science sub-segments.
• Syneos Health Communications: Syneos Health is a large biopharmaceutical services organization with a communications arm serving life science clients. Broader incumbent competing in the same life science PR/marketing space with significantly greater scale and clinical services adjacency.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/zymecomms
• Facebookfacebook.com/100054516938297
• LinkedInlinkedin.com/company/zyme-communications-ltd

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Zyme Communications